News

A Brush with Climate, for example, is developing workshops to empower hairdressers to steer conversations toward climate ...
SYNT-101 offers a novel approach to weight loss by temporarily altering nutrient absorption in the small intestine. Unlike ...
A judge issued her order after Trump officials continually refused to retrieve Abrego Garcia, saying they defied a ...
Q1 2025 Earnings Conference Call April 15, 2025 9:40 AM ETCompany ParticipantsGregory Lundberg - Investor RelationsJohn Wren ...
iGEM uOttawa seeks sustainable semaglutide production amid Ozempic shortage. Credit: Amelia Adams Phytogene uses Nicotiana benthamiana, a relative of the tobacco plant, to produce medications like GLP ...
Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...
the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil to boost production, it said on Monday. The investment aims to increase manufacturing ...
April 14 (Reuters) - Danish drugmaker Novo Nordisk NOVOb.CO said on Monday several hundred counterfeit units of its diabetes drug Ozempic were being distributed outside its authorized supply chain ...
This expansion aims to double the plant's size and enhance production capacity for diabetes and obesity treatments, including its blockbuster drugs Ozempic and Wegovy. The announcement ...
April 14 (UPI) --The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to treat Type 2 diabetes, have been found in the United States.
Novo Nordisk, the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...
As medical professionals and researchers continue searching for effective treatments, a drug called Ozempic (semaglutide) has emerged as a potential therapy. Originally approved for type 2 ...